Lipocine (LPCN) Shares Outstanding (Entity) (2011 - 2025)
Lipocine (LPCN) reported Shares Outstanding (Entity) of 5.42 million for Q3 2025, up 1.4% from 5.35 million a year earlier and up 0.9% from the prior quarter.
Lipocine (LPCN) Shares Outstanding (Entity) (2011 - 2025) Analysis & Trends
For FY2024, Lipocine posted Shares Outstanding (Entity) of 5.35 million, up 0.6% from FY2023.
- Shares Outstanding (Entity) has increased for 13 consecutive years, with a five-year compound annual growth rate of 28.6% (FY2019 to FY2024).
- By year, Shares Outstanding (Entity) came in at 5.32 million in FY2023 (+2.1%), 5.21 million in FY2022 (+0.2%), 5.19 million in FY2021 (+58.5%) and 3.28 million in FY2020 (+115.2%).
- The Q3 2025 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to Q4 2011.
- Year over year, Shares Outstanding (Entity) has now increased in each of the last ten quarters, with growth averaging 1.3% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 0.0% in Q1 2023 to 115.2% in Q4 2020.
- Per Business Quant data, the three quarters before Q3 2025 came in at 5.37 million (Q2 2025), 5.35 million (Q1 2025) and 5.35 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Lipocine | 11.92 Mn | -55.79 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 5.42 Mn |
| Jun 30, 2025 | 5.37 Mn |
| Mar 31, 2025 | 5.35 Mn |
| Dec 31, 2024 | 5.35 Mn |
| Sep 30, 2024 | 5.35 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 5.32 Mn |
| Dec 31, 2023 | 5.32 Mn |
| Sep 30, 2023 | 5.32 Mn |
| Jun 30, 2023 | 5.23 Mn |
| Mar 31, 2023 | 5.21 Mn |
| Dec 31, 2022 | 5.21 Mn |
| Sep 30, 2022 | 5.21 Mn |
| Jun 30, 2022 | 5.21 Mn |
| Mar 31, 2022 | 5.21 Mn |
| Dec 31, 2021 | 5.19 Mn |
| Sep 30, 2021 | 5.19 Mn |
| Jun 30, 2021 | 5.19 Mn |
| Mar 31, 2021 | 5.19 Mn |
| Dec 31, 2020 | 3.28 Mn |
Lipocine Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=LPCN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();